A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma

Figure 3

The diagnostic value of serum lncRNAs in patients with HCC. (a) The diagnostic value of HULC, MALAT1, Linc00152, PTENP1, PTTG3P, SPRY4-IT1, UBE2CP3, and UCA1 was evaluated by ROC analysis when patients with HCC were tested against patients with healthy controls. (b) Diagnosis efficacy for HULC, MALAT1, Linc00152, PTENP1, PTTG3P, SPRY4-IT1, UBE2CP3, and UCA1 to distinguish HCC patients from CHB patients, LC patients, and healthy controls. (c) Diagnosis efficacy of the combinations of serum lncRNAs with AFP to discriminate HCC from CHB patients, LC patients, and healthy controls. (d) Diagnosis efficacy of the diagnostic panel established by serum lncRNAs (Linc00512 and UCA1) and AFP.

(a)

(b)

(c)

(d)